SMART (Symbicort [budesonide/formoterol] maintenance and reliever therapy): Reassure program for patients using Symbicort Turbuhaler as maintenance and reliever therapy in Korean clinical practice

Trial Profile

SMART (Symbicort [budesonide/formoterol] maintenance and reliever therapy): Reassure program for patients using Symbicort Turbuhaler as maintenance and reliever therapy in Korean clinical practice

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2008

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 05 Oct 2008 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
    • 05 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Sep 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top